Author:
Frassetto Fernando Pereira,Rosemberg Sergio
Abstract
Abstract
Background
Yellow fever is a viral hemorrhagic fever caused by yellow fever virus, a mosquito-borne flavivirus. Despite an effective vaccine, major outbreaks continue to occur around the world. Even though it is not a proven neurotropic virus, neurological symptoms in more severe clinical forms are frequent. The understanding of this apparent paradox is still rarely addressed in literature.
Methods
The brains of thirty-eight patients with yellow fever confirmed by RT-PCR, who underwent autopsy, were analyzed morphologically to identify and characterize neuropathological changes. The data were compared with brains collected from individuals without the disease, as a control group. Both cases and controls were subdivided according to the presence or absence of co-concurrent septic shock, to exclude changes of the sepsis associated encephalopathy. To verify possible morphological differences between the yellow fever cases groups, between the control groups, and between the cases and the controls, we applied the statistical tests Fisher's exact test and chi-square, with p values < 0.05 considered statistically significant.
Results
All cases and controls presented, at least focally, neuropathological changes, which included edema, meningeal and parenchymal inflammatory infiltrate and hemorrhages, and perivascular inflammatory infiltrate. We did not find an unequivocal aspect of encephalitis. The only parameter that, after statistical analysis, can be attributed to yellow fever was the perivascular inflammatory infiltrate.
Conclusions
The neuropathological findings are sufficient to justify the multiple clinical neurologic disturbances detected in the YF cases. Since most of the parameters evaluated did not show statistically significant difference between cases and controls, an explanation for most of the neuropathological findings may be the vascular changes, consequent to shock induced endotheliopathy, associated with stimulation of the immune system inherent to systemic infectious processes. The statistical difference obtained in yellow fever cases regarding perivascular infiltrate can be can be explained by the immune activation inherent to the condition.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference36 articles.
1. Kleinert RDV, Montoya-Diaz E, Khera T, et al. Yellow fever: Integrating current knowledge with technological innovations to identify strategies for controlling a re-emerging virus. Viruses. 2019;11:960.
2. Jones EM, Wilson DC. Clinical features of yellow fever cases at Vom Christian Hospital during the 1969 epidemic on the Jos Plateau. Nigeria Bull World Health Organ. 1972;46(5):653–7.
3. Ekenna O, Chikwem JO, Mohammed I, Durojaiye SO. Epidemic yellow fever in Borno State of Nigeria: characterization of hospitalized patients. West Afr J Med. 2010;29(2):91–7.
4. Kwagonza L, Masiira B, Kyobe-Bosa H, et al. Outbreak of yellow fever in central and southwestern Uganda, February-may 2016. BMC Infect Dis. 2018;18(1):548.
5. Alhakimi HA, Mohamed OG, Khogaly HSE, Arafa KAO, Ahmed WA. Epidemiological, Clinical and Entomological Characteristics of Yellow Fever Outbreak in Darfur 2012. AIMS Public Health. 2015;2(1):132–41.